Lymphocytotoxic antibody in inflammatory bowel disease. A family study.

The New England Journal of Medicine
S J KorsmeyerR G Strickland

Abstract

The prevalence of lymphocytotoxic antibody in inflammatory bowel disease is 40 per cent. Twenty-seven of 90 relatives of 23 probands with the disease (30 per cent) demonstrated lymphocytotoxic antibody, as contrasted with only three of 69 control family members (4 per cent) (P less than 0.0001). Decreased lymphocytotoxicity against lymphocytes from patients with inflammatory bowel disease as compared to normal donor lymphocytes previously demonstrated in the serum of probands was also observed in the serums from family members of the probands. Nineteen of the 48 household contacts of probands (40 per cent) were positive for antibody, whereas eight of 42 nonhousehold contacts (19 per cent) demonstrated it (P less than 0.05). Eight of 16 spouses (50 per cent) of probands showed antibody. The increased prevalence of lymphocytotoxic antibody in family members of probands and its occurrence mainly in household contacts (consanguineous and non-consanguineous) may indicate the exposure of probands and their family members to a common environmental agent.

References

Jan 1, 1975·The Journal of Experimental Medicine·Y ObataE A Boyse
Jun 1, 1975·The Journal of Clinical Investigation·R J DeHoratius, R P Messner
Jul 25, 1970·Lancet·D N Mitchell, R J Rees
Aug 8, 1970·Lancet·G A MacGregor
Dec 1, 1973·The Journal of Clinical Investigation·R P MessnerR C Williams
Apr 1, 1974·Clinical Immunology and Immunopathology·R J DeHoratiusR C Williams
Jul 1, 1971·The Journal of Clinical Investigation·R C WilliamsE J Yunis
Oct 1, 1970·The New England Journal of Medicine·P I TerasakiE V Barnett
Mar 28, 1970·Nature·K K MittalW T Butler
Nov 1, 1970·Transplantation·M J KreislerP I Terasaki
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND
Jan 1, 1966·Scandinavian Journal of Gastroenterology·Vibeke BinderP Rus

❮ Previous
Next ❯

Citations

Oct 1, 1979·Arthritis and Rheumatism·A L Schocket, P F Kohler
Apr 1, 1996·Inflammatory Bowel Diseases·R H Duerr
Apr 1, 1982·Digestive Diseases and Sciences·J L AchordJ F Jackson
Sep 1, 1985·Digestive Diseases and Sciences·A ParésJ Rodés
Jan 1, 1991·Immunologic Research·F ShanahanS R Targan
May 1, 1992·Immunology Today·G A Rook, J L Stanford
Jul 19, 2013·Journal of Autoimmunity·Mohamad H ImamKeith D Lindor
Jun 14, 2003·Gastroenterology·Bjarni ThjodleifssonIngvar Bjarnason
Sep 14, 2001·Journal of Gastroenterology and Hepatology·C OsangthamnontS Boonyapisit
Jan 1, 1976·Scandinavian Journal of Immunology·C A HendersonR G Strickland
Aug 1, 1988·Digestive Diseases and Sciences·A Van GossumJ Wybran
Apr 1, 1984·The Journal of General Psychology·J B Murray
Jan 22, 1979·Blut·T A Shiftan, J Mendelsohn
May 24, 2008·Gastroenterology Clinics of North America·Severine VermeirePaul Rutgeerts
Mar 1, 1997·Baillière's Clinical Gastroenterology·P R Gibson
Sep 1, 1982·The British Journal of Dermatology·A L SchocketD A Norris
Jan 1, 1977·Clinical Immunology and Immunopathology·A L SchocketP F Kohler
Jul 2, 2016·Therapeutic Advances in Gastroenterology·Natalie E Duran, Daniel W Hommes
Nov 6, 2001·The American Journal of Gastroenterology·N P BreslinL R Sutherland
Aug 26, 1998·The American Journal of Gastroenterology·B SendidJ F Colombel
Jan 1, 1981·Scandinavian Journal of Gastroenterology·P J Whorwell
Aug 1, 1993·Immunology and Cell Biology·B R Yacyshyn
Feb 1, 1995·Scandinavian Journal of Gastroenterology·G SchumacherL Nässberger
Mar 1, 1980·Tissue Antigens·J C CicciarelliS Shirahama
Jul 22, 1978·Lancet·P J WhorwellJ Bamforth
Oct 1, 1991·Disease-a-month : DM·J B Kirsner
Jan 1, 1985·Critical Reviews in Oncology/hematology·J FaintuchJ B Kirsner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.